ALFA Finder| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 3676.0 | 3080.0 | 2715.0 |
| Other income | 94.0 | 64.0 | 145.0 |
| Total income | 3770.0 | 3144.0 | 2860.0 |
| Profit before exceptional items & tax | 1505.0 | 1180.0 | 912.0 |
| Profit before tax | 1505.0 | 1180.0 | 912.0 |
| Net profit | 1127.0 | 902.0 | 689.0 |
| Operating margin | 39.9% | 37.5% | 31.9% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +63.60% |
|---|---|
| Net profit, quarter on quarter | +24.90% |
| Revenue, year on year | +35.40% |
| Operating profit, year on year | +84.00% |
| Operating profit, quarter on quarter | +26.40% |
NSE results filing, NSE: DIVISLAB. Figures extracted from the filing.
Divi's Laboratories Ltd: key numbers
- Share price
- ₹10,320.50
- Market cap
- ₹2,73,977 Cr
- Revenue (annual)
- ₹10,560 Cr
- Net profit (annual)
- ₹2,568 Cr
- P/E (TTM)
- 93.7×Sector 43.0×
- Promoter holding
- 51.88%+0.00% QoQ
- FII holding
- 20.38%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Divi's Laboratories Ltd
All →Divi's Laboratories Board Meeting Date
Divi's Laboratories will hold a board meeting on November 07, 2026, to approve unaudited standalone and consolidated financial results for the quarter ended September 30, 2026.
Divi's Laboratories Other Announcement
Divis Laboratories Ltd has submitted its quarterly shareholding pattern as of September 30, 2026, in compliance with SEBI Regulation 31.
Divi's Laboratories Other Announcement
Immediate relatives of the company purchased 462 shares for a total consideration of Rs. 0.43 Crore in the open market.
- Value
- ₹0.43 Cr
Divi's Laboratories Other Announcement
Divis Laboratories Ltd reported a share pledge by Designated Person Nimmagadda Venkata Anirudh involving securities valued at ₹3.33 Crore. Additionally, Joshita Divi acquired shares worth ₹0.96 Crore via market purchase.
- Value
- ₹4.29 Cr
Divi's Laboratories Other Announcement
An immediate relative of a Divis Laboratories promoter bought equity shares worth ₹0.58 Crore through a market purchase.
- Value
- ₹0.58 Cr
Divi's Laboratories Other Announcement
Designated Person PRASAD Y.T.S. disclosed the release of two share pledges involving 2,734 equity shares. The combined transaction value of the released pledges is Rs. 2.56 Crore.
- Value
- ₹2.56 Cr